We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ionis Pharmaceuticals has a 12-month low of $30.23 and a 12-month high of $52.34. The business’s 50 day moving average is $32.66 and its 200 day moving average is $36.47.
Sideral has officially acquired the distribution rights for Eloy Calvo’s buzzy Spanish mixed-media feature “The Van” (“La Furgo”). The film will premiere at the BCN Film Festival on ...
I find the reliability of the chevy van and smooth ride has worked very well for me in anything I put it up to.
CARLSBAD, Calif. & OSAKA, Japan, March 11, 2025--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced ...
Jeanicmar Rangel caught the moment the tornado passed over. Rangel was trapped inside her work van at the time. "Aye Dios mio!" Rangel can be heard crying in the video. The video shows debris ...
A man was arrested in Fairfield on Monday after police said he hit two police cruisers, a medical transport van and another car during a pursuit, injuring seven people.It started around 12:30 p.m ...
A makeshift and growing RV Park just off Highway 1 in North Vancouver is the source of growing worry for neighbours and the city. About a dozen people are living in RVs and temporary structures on ...
If not treated, ATTRv-PN patients can lose sensation in their legs and feet. Credit: ljubaphoto via Getty Images. AstraZeneca and Ionis Pharmaceuticals’ polyneuropathy drug has won approval in the ...
Blotnicki, 32, of Glenview. A woman has been sentenced to 40 days in jail after she pleaded guilty to keeping over two dozen cats in a U-Haul van for months, resulting in severe medical issues, in ...
The world's smallest camper van sounds a bit like clickbait, doesn't it? Well, as you'll soon see, it's not. These two guys actually turned a tiny van into a simple mobile home designed for short ...
When some for­mer MyoKar­dia ex­ecs re­unit­ed with $300 mil­lion for a new “heart health” biotech ear­li­er this year, they were ...